Publication Name	World Journal of Gastroenterology
Manuscript ID	100250
Country	Taiwan

Received	2024-08-21 06:35
Peer-Review Started	2024-08-11 07:52
To Make the First Decision
Return for Revision	2024-10-22 01:55
Revised	2024-10-31 03:33
Second Decision	2024-11-18 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-11-18 05:29
Articles in Press	2024-11-18 05:29
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-11-21 02:24
Publish the Manuscript Online	2024-12-09 10:40

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Fanlian Huazhuo formula: A promising therapeutic approach for metabolic associated steatotic liver disease
Manuscript Source	Invited Manuscript
All Author List	Chun-Han Cheng, Wen-Rui Hao and Tzu-Hurng Cheng
ORCID	Author(s) ORCID Number Tzu-Hurng Cheng http://orcid.org/0000-0002-9155-4169
Funding Agency and Grant Number
Corresponding Author	Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung 404328, Taiwan. thcheng@mail.cmu.edu.tw
Key Words	Fanlian Huazhuo formula; Metabolic associated steatotic liver disease; Autophagy; Lipid metabolism; Oxidative stress
Core Tip	This article highlight the key findings of a study that Fanlian Huazhuo formula (FLHZF) is effective in treating metabolic-associated steatotic liver disease (MASLD) by reducing lipid accumulation, oxidative stress, and liver injury. FLHZF achieves these benefits by modulating autophagy and lipid metabolism pathways. These results underscore FLHZF’s potential as a therapeutic option for MASLD and emphasize the requirement for further clinical trials to validate its efficacy and safety in larger patient populations.
Publish Date	2024-12-09 10:40
Citation	<p>Cheng CH, Hao WR, Cheng TH. Fanlian Huazhuo formula: A promising therapeutic approach for metabolic associated steatotic liver disease. <i>World J Gastroenterol</i> 2025; 31(1): 100250</p>
URL	https://www.wjgnet.com/1007-9327/full/v31/i1/100250.htm
DOI	https://dx.doi.org/10.3748/wjg.v31.i1.100250

Full Article (PDF)	WJG-31-100250-with-cover.pdf
Manuscript File	100250_Auto_Edited_030148.docx
Answering Reviewers	100250-answering-reviewers.pdf
Audio Core Tip	100250-audio.mp3
Conflict-of-Interest Disclosure Form	100250-conflict-of-interest-statement.pdf
Copyright License Agreement	100250-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	100250-non-native-speakers.pdf
Peer-review Report	100250-peer-reviews.pdf
Scientific Misconduct Check	100250-scientific-misconduct-check.png
Scientific Editor Work List	100250-scientific-editor-work-list.pdf
CrossCheck Report	100250-crosscheck-report.pdf